Marodyne-LiV, part number 3045-133, Low intensity vibration exerciser supporting osteoporosis treatment — FDA record Z-3162-2024

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Aug 1, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Marodyne-LiV, part number 3045-133, Low intensity vibration exerciser supporting osteoporosis treatment
Reason
Some power supply units in Austria and Germany had a voltage drop in the millisecond range, which led to a cancellation of the treatment and subsequent restart of the medical device. The treatment is only restarted by a step-off/step-on (step-on for activation).
Classification
Class II
Recalling firm
Btt Health Gmbh
Quantity
62 units
Agency-reported status
Ongoing
Source record identifier
Z-3162-2024

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityserial numbers: 010426065891001421S05327911240506, 010426065891001421S05328011240506, 010426065891001421S05328111240506, 010426065891001421S05328211240506, 010426065891001421S05328311240506, 010426065891001421S05328411240506, 010426065891001421S05328511240506, 010426065891001421S05328611240506, 010426065891001421S05328711240506, 010426065891001421S05328811240506, 010426065891001421S05328911240506, 010426065891001421S05329011240506, 010426065891001421S05321911240430, 010426065891001421S05322011240430, 010426065891001421S05322111240430, 010426065891001421S05322211240430, 010426065891001421S05322311240430, 010426065891001421S05322411240430, 010426065891001421S05322511240430, 010426065891001421S05322611240430, 010426065891000721S05336411240521, 010426065891000721S05336511240521, 010426065891000721S05336611240521, 010426065891000721S05336711240521, 010426065891000721S05336811240521, 010426065891000721S05336911240521, 010426065891000721S05337011240521, 010426065891000721S05337111240521, 010426065891000721S05337211240521, 010426065891000721S05337311240521, 010426065891000721S05337411240521, 010426065891000721S05337511240521, 010426065891000721S05337611240521, 010426065891000721S05337711240521, 010426065891000721S05337811240521, 010426065891000721S05337911240521, 010426065891000721S05338011240521, 010426065891000721S05338111240521, 010426065891000721S05338211240521, 010426065891000721S05338311240521, 010426065891000721S05338411240521, 010426065891000721S05338511240521, 010426065891000721S05338611240521, 010426065891000721S05338711240521, 010426065891000721S05338811240521, 010426065891000721S05338911240521, 010426065891000721S05339011240521, 010426065891000721S05339111240521, 010426065891000721S05339211240521, 010426065891000721S05339311240521, 010426065891000721S05339411240521, 010426065891000721S05339511240521, 010426065891000721S05339611240521, 010426065891000721S05339711240521, 010426065891000721S05339811240521, 010426065891000721S05339911240521, 010426065891000721S05340011240521, 010426065891000721S05340111240521, 010426065891000721S05340211240521, 010426065891000721S05340311240521, 010426065891000721S05340411240521, 010426065891000721S05340511240521

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US Nationwide distribution in the states of Florida.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Sep 25, 2024
Recall initiation date
Aug 1, 2024
Center classification date
Sep 17, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records